[1] Seay K, Church C, Zheng J H, et al. In Vivo Activation of Human NK Cells by Treatment with an Interleukin–15 Superagonist Potently Inhibits Acute In Vivo HIV–1 Infection in Humanized Mice[J]. J Virol,2015,89(12):6264–6274.
[2] Jost S, Altfeld M. Control of human viral infections by natural killer cells[J]. Annu Rev Immunol,2013,31:163–194.
[3] Parham P, Moffett A. Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution[J]. Nat Rev Immunol,2013,13(2):133–144.
[4] Abi-Rached L, Moesta A K, Rajalingam R, et al. Human-specific evolution and adaptation led to major qualitative differences in the variable receptors of human and chimpanzee natural killer cells[J]. PLoS Genet,2010,6(11):e1001192.
[5] Winter C C, Gumperz J E, Parham P, et al. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition[J]. J Immunol,1998,161(2):571–577.
[6] Korner C, Granoff M E, Amero M A, et al. Increased frequency and function of KIR2DL1–3(+) NK cells in primary HIV–1 infection are determined by HLA-C group haplotypes[J]. Eur J Immunol,2014,44(10):2938–2948.
[7] Campbell K S, Purdy A K. Structure/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations[J]. Immunology,2011,132(3):315–325.
[8] Stanietsky N, Mandelboim O. Paired NK cell receptors controlling NK cytotoxicity[J]. FEBS Lett,2010,584(24):4895–4900.
[9] Habegger D S A, Sinchi J L, Marinic K, et al. KIR-HLA-A and B alleles of the Bw4 epitope against HIV infection in discordant heterosexual couples in Chaco Argentina[J]. Immunology,2013,140(2):273–279.
[10] Koehler R N, Alter G, Tovanabutra S, et al. Natural killer cell-mediated innate sieve effect on HIV–1: the impact of KIR/HLA polymorphism on HIV–1 subtype-specific acquisition in east Africa[J]. J Infect Dis,2013,208(8):1250–1254.
[11] Bashirova A A, Thomas R, Carrington M. HLA/KIR Restraint of HIV: Surviving the Fittest[J]. Annual Review of Immunology,2011,29(1):295–317.
[12] Lifson J D, Nowak M A, Goldstein S, et al. The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection[J]. J Virol,1997,71(12):9508–9514.
[13] Prentice H A, Tang J. HIV–1 dynamics: a reappraisal of host and viral factors, as well as methodological issues[J]. Viruses,2012,4(10):2080–2096.
[14] Tang J, Li X, Price M A, et al. CD4:CD8 lymphocyte ratio as a quantitative measure of immunologic health in HIV–1 infection: findings from an African cohort with prospective data[J]. Front Microbiol,2015,6:670.
[15] Hema M N, Ferry T, Dupon M, et al. Low CD4/CD8 Ratio Is Associated with Non AIDS-Defining Cancers in Patients on Antiretroviral Therapy: ANRS CO8 (Aproco/Copilote) Prospective Cohort Study[J]. PLoS One,2016,11(8):e161594.
[16] Hoenigl M, Chaillon A, Little S J. CD4/CD8 Cell Ratio in Acute HIV Infection and the Impact of Early Antiretroviral Therapy[J]. Clin Infect Dis,2016,63(3):425–426.
[17] Sandler N G, Wand H, Roque A, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection[J]. J Infect Dis,2011,203(6):780–790.
[18] Hunt P W, Cao H L, Muzoora C, et al. Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy[J]. AIDS,2011,25(17):2123–2131.
[19] Mori M, Wichukchinda N, Miyahara R, et al. The effect of KIR2D–HLA-C receptor–ligand interactions on clinical outcome in a HIV–1 CRF01_AE-infected Thai population[J]. AIDS,2015,29(13):1607–1615.
[20] Bachle S M, Malone D F, Buggert M, et al. Elevated levels of invariant natural killer T-cell and natural killer cell activation correlate with disease progression in HIV–1 and HIV–2 infections[J]. AIDS,2016,30(11):1713–1722.
[21] Song R, Lisovsky I, Lebouché B, et al. HIV Protective KIR3DL1/S1-HLA-B Genotypes Influence NK Cell-Mediated Inhibition of HIV Replication in Autologous CD4 Targets[J]. PLoS Pathogens,2014,10(1):e1003867.
[22] Zhang F, Liu L, Sun M, et al. An analysis of drug resistance among people living with HIV/AIDS in Shanghai, China[J]. PLoS One,2017,12(2):e165110.
[23] Kulkarni S, Martin M P, Carrington M. KIR genotyping by multiplex PCR-SSP[J]. Methods Mol Biol,2010,612:365–375.
[24] Trachtenberg E A, Holcomb C L. Next-generation HLA sequencing using the 454 GS FLX system[J]. Methods Mol Biol,2013,1034:197–219.
[25] Ayo C M, Reis P G, Dalalio M M D O, et al. Killer Cell Immunoglobulin-like Receptors and Their HLA Ligands are Related with the Immunopathology of Chagas Disease[J]. PLOS Neglected Tropical Diseases,2015,9(5):e3753.
[26] van Duin D, Avery R K, Hemachandra S, et al. KIR and HLA Interactions Are Associated With Control of Primary CMV Infection in Solid Organ Transplant Recipients[J]. American Journal of Transplantation,2014,14(1):156–162.
[27] Guo X, Zhang Y, Li J, et al. Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population[J]. Hepatology,2011,53(2):422–428.
[28] Venstrom J M, Zheng J, Noor N, et al. KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma[J]. Clin Cancer Res,2009,15(23):7330–7334.
[29] Jiang Y, Chen O, Cui C, et al. KIR3DS1/L1 and HLA-Bw4–80I are associated with HIV disease progression among HIV typical progressors and long-term nonprogressors[J]. BMC Infect Dis,2013,13:405.
[30] Lu C, Shen Y J, Deng Y F, et al. Association of killer cell immunoglobulin-like receptors with pulmonary tuberculosis in Chinese Han[J]. Genet Mol Res,2012,11(2):1370–1378.
[31] Roberts L, Passmore J A, Mlisana K, et al. Genital tract inflammation during early HIV–1 infection predicts higher plasma viral load set point in women[J]. J Infect Dis,2012,205(2):194–203.
[32] Zhang Z, Hu S, Liu J, et al. CD4+CD38+HLA-DR+ cells: a predictor of viral set point in Chinese men with primary HIV infection who have sex with men[J]. Jpn J Infect Dis,2011,64(5):423–425.
[33] Wei Z, Liu Y, Xu H, et al. Genome-Wide Association Studies of HIV–1 Host Control in Ethnically Diverse Chinese Populations[J]. Scientific Reports,2015,5:10879.
[34] Huang X, Chen H, Li W, et al. Precise determination of time to reach viral load set point after acute HIV–1 infection[J]. J Acquir Immune Defic Syndr,2012,61(4):448–454.
[35] Ahlenstiel G, Martin M P, Gao X, et al. Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses[J]. J Clin Invest,2008,118(3):1017–1026.
[36] Alter G, Rihn S, Walter K, et al. HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection[J]. J Virol,2009,83(13):6798–6805.
[37] Alter G, Martin M P, Teigen N, et al. Differential natural killer cell mediated inhibition of HIV–1 replication based on distinct KIR/HLA subtypes[J]. Journal of Experimental Medicine,2007,204(12):3027–3036.
[38] Cohen G B, Gandhi R T, Davis D M, et al. The selective downregulation of class I major histocompatibility complex proteins by HIV–1 protects HIV-infected cells from NK cells[J]. Immunity,1999,10(6):661–671.
[39] Martini F, Agrati C, D’Offizi G, et al. HLA-E up-regulation induced by HIV infection may directly contribute to CD94-mediated impairment of NK cells[J]. Int J Immunopathol Pharmacol,2005,18(2):269–276.
[40] Le Gall S, Erdtmann L, Benichou S, et al. Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules[J]. Immunity,1998,8(4):483–495.
[41] Korner C, Granoff M E, Amero M A, et al. Increased frequency and function of KIR2DL1–3(+) NK cells in primary HIV–1 infection are determined by HLA-C group haplotypes[J]. Eur J Immunol,2014,44(10):2938–2948.
[42] Anas A, van der Poll T, de Vos A F. Role of CD14 in lung inflammation and infection[J]. Crit Care,2010,14(2):209.